{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:42:23Z","timestamp":1794440543945,"version":"4.9.1"},"reference-count":32,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2253,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1111\/j.1468-3083.2009.03181.x","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T05:00:13Z","timestamp":1236315613000},"page":"803-806","source":"Crossref","is-referenced-by-count":74,"title":["Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control"],"prefix":"10.1111","volume":"23","author":[{"given":"A","family":"Nofal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Al-Makhzangy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Attwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Abdalmoati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199503023320907","article-title":"Treatment of psoriasis","volume":"332","author":"Greaves","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB2","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1038\/sj.jid.5700874","article-title":"Upregulation of hypoxia-inducible factors in normal and psoriatic skin","volume":"127","author":"Rosenberger","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cca.2008.04.005","article-title":"Cytokines and anticytokines in psoriasis","volume":"394","author":"Pietrzak","year":"2008","journal-title":"Clin Chim Acta"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB4","doi-asserted-by":"crossref","first-page":"xiv","DOI":"10.1046\/j.0022-202X.2003.22140.x","article-title":"Evidence for vascular endothelial growth factor (VEGF) as a modifier gene in psoriasis","volume":"122","author":"Detmar","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB5","first-page":"233","article-title":"Vascular permeability factor\/vascular endothelial growth factor: a multifunctional angiogenic cytokine","volume":"79","author":"Brown","year":"1997","journal-title":"EXS"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB6","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.180.3.1141","article-title":"Overexpression of vascular permeability factor\/vascular endothelial growth factor and its receptors in psoriasis","volume":"180","author":"Detmar","year":"1994","journal-title":"J Exp Med"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB7","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1046\/j.1365-2133.1999.03205.x","article-title":"Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis","volume":"141","author":"Bhushan","year":"1999","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB8","first-page":"358","article-title":"Vascular endothelial growth factor, vascular endothelial growth factor receptor-3 and cyclooxygenase-2 expression in psoriasis","volume":"29","author":"Yal\u00e7in","year":"2007","journal-title":"Anal Quant Cytol Histol"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB9","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1582-4934.2007.00112.x","article-title":"Overexpression of vascular endothelial growth factor (VEGF) receptors on keratinocytes in psoriasis: regulated by calcium independent of VEGF","volume":"12","author":"Man","year":"2008","journal-title":"J Cell Mol Med"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/039463200601900405","article-title":"VEGF is likely a key factor in the link between inflammation and angiogenesis in psoriasis: results of an immunohistochemical study","volume":"19","author":"Simonetti","year":"2006","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2230.1995.tb01274.x","article-title":"Vascular proliferation and angiogenic factors in psoriasis","volume":"20","author":"Creamer","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB12","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(05)64447-9","article-title":"Circulating vascular permeability factor\/vascular endothelial growth factor in erythroderma","volume":"348","author":"Creamer","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB13","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1001\/archderm.138.6.791","article-title":"Mediation of systemic vascular hyperpermeability in severe psoriasis by circulating vascular endothelial growth factor","volume":"138","author":"Creamer","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/PL00012428","article-title":"Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis","volume":"51","author":"Nielsen","year":"2002","journal-title":"Inflamm Res"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.0022-202X.2003.22107.x","article-title":"Single-nucleotide polymorphisms of vascular endothelial growth factor in psoriasis of early onset","volume":"122","author":"Young","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB16","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00403-006-0723-8","article-title":"Angiogenic activity in patients with psoriasis is significantly decreased by Goeckerman's therapy","volume":"298","author":"Andrys","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB17","first-page":"305","article-title":"Vascular endothelial growth factor in patients with psoriatic arthritis","volume":"25","author":"Fink","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB18","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1196\/annals.1423.062","article-title":"Effective therapy with anti-TNF-\u03b1 in patients with psoriatic arthritis is associated with decreased levels of metalloproteinases and angiogenic cytokines in the sera and skin lesions","volume":"1110","author":"Cordiali-Fei","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB19","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1600-0781.2008.00349.x","article-title":"Discrepant levels of vascular endothelial growth factor in psoriasis patients treated with PUVA, Re-PUVA and narrow-band UVB","volume":"24","author":"Akman","year":"2008","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1182\/blood-2002-12-3793","article-title":"Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis","volume":"102","author":"Xia","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB21","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaad.2005.04.035","article-title":"Psoriasis - recent advances in understanding its pathogenesis and treatment","volume":"53","author":"Krueger","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB22","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis - oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1358\/dnp.2008.21.2.1188196","article-title":"Angiogenesis: the new potential target for the therapy of psoriasis?","volume":"21","author":"Heidenreich","year":"2008","journal-title":"Drug News Perspect"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/sj.jid.5700096","article-title":"Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis","volume":"126","author":"Young","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB25","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0140-6736(91)90357-U","article-title":"The pathophysioology of psoriasis","volume":"338","author":"Barker","year":"1993","journal-title":"Lancet"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1177\/12034754020060S302","article-title":"Pathophysiology of psoriasis: science behind therapy","volume":"6","author":"Guenther","year":"2002","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1159\/000248567","article-title":"Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis","volume":"177","author":"Saurat","year":"1988","journal-title":"Dermatologica"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB28","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1067\/mjd.2001.116347","article-title":"Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis","volume":"45","author":"Lebwohl","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB29","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1074\/jbc.275.1.642","article-title":"Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids","volume":"275","author":"Diaz","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB30","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.jaad.2007.05.021","article-title":"Sirolimus (rapamycin): from the soil of Easter Island to a bright future","volume":"57","author":"Paghdal","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2353\/ajpath.2008.071074","article-title":"Inhibition of chronic and acute skin inflammation by treatment with a vascular endothelial growth factor receptor tyrosine kinase inhibitor","volume":"173","author":"Halin","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1468-3083.2009.03181.x-BIB32","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jaad.2006.01.038","article-title":"Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy","volume":"54","author":"Markham","year":"2006","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2009.03181.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1468-3083.2009.03181.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T01:26:18Z","timestamp":1625534778000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2009.03181.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03181.x","relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}